Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for March 3, 2025 at 4:30 P.M. Eastern Time
Senseonics Holdings (NYSE American: SENS), a medical technology company specializing in long-term, implantable continuous glucose monitoring systems for diabetes patients, has scheduled its fourth quarter and full year 2024 earnings release for March 3, 2025, after market close.
The company will host a conference call at 4:30 P.M. Eastern Time on the same day to discuss the financial results. Investors can access the call by dialing 1-800-445-7795 (US/Canada) or 1-785-424-1699 (International) using passcode SENSQ4. A concurrent webcast will be available on the company's website under the Investor Relations section and will be archived for future reference.
Senseonics Holdings (NYSE American: SENS), un'azienda di tecnologia medica specializzata in sistemi di monitoraggio continuo della glicemia impiantabili a lungo termine per pazienti diabetici, ha programmato il suo rilascio dei risultati finanziari del quarto trimestre e dell'intero anno 2024 per il 3 marzo 2025, dopo la chiusura del mercato.
L'azienda ospiterà una conferenza telefonica alle 16:30 ora orientale dello stesso giorno per discutere i risultati finanziari. Gli investitori possono accedere alla chiamata componendo il numero 1-800-445-7795 (US/Canada) o 1-785-424-1699 (Internazionale) utilizzando il codice di accesso SENSQ4. Sarà disponibile una diretta streaming sul sito web dell'azienda nella sezione Relazioni con gli Investitori e sarà archiviata per riferimento futuro.
Senseonics Holdings (NYSE American: SENS), una empresa de tecnología médica especializada en sistemas implantables de monitoreo continuo de glucosa a largo plazo para pacientes diabéticos, ha programado su publicación de resultados financieros del cuarto trimestre y del año completo 2024 para el 3 de marzo de 2025, después del cierre del mercado.
La empresa llevará a cabo una conferencia telefónica a las 4:30 P.M. hora del Este el mismo día para discutir los resultados financieros. Los inversores pueden acceder a la llamada marcando el 1-800-445-7795 (EE.UU./Canadá) o el 1-785-424-1699 (Internacional) utilizando el código de acceso SENSQ4. También habrá una transmisión web disponible en el sitio web de la empresa en la sección de Relaciones con Inversores y se archivará para referencia futura.
센소닉스 홀딩스 (NYSE American: SENS)는 당뇨병 환자를 위한 장기 이식 가능한 지속적인 혈당 모니터링 시스템을 전문으로 하는 의료 기술 회사로, 2024년 4분기 및 연간 실적 발표를 2025년 3월 3일 시장 종료 후에 예정하고 있습니다.
회사는 같은 날 동부 표준시 기준 오후 4시 30분에 재무 결과를 논의하기 위한 컨퍼런스 콜을 진행할 예정입니다. 투자자는 1-800-445-7795 (미국/캐나다) 또는 1-785-424-1699 (국제)로 전화하여 SENSQ4 비밀번호를 사용하여 통화에 참여할 수 있습니다. 회사 웹사이트의 투자자 관계 섹션에서 동시 웹캐스트가 제공되며, 미래 참조를 위해 아카이브될 것입니다.
Senseonics Holdings (NYSE American: SENS), une entreprise de technologie médicale spécialisée dans les systèmes de surveillance continue de la glycémie implantables à long terme pour les patients diabétiques, a programmé la publication de ses résultats financiers du quatrième trimestre et de l'année 2024 pour le 3 mars 2025, après la clôture du marché.
L'entreprise organisera un appel conférence à 16h30, heure de l'Est, le même jour pour discuter des résultats financiers. Les investisseurs peuvent accéder à l'appel en composant le 1-800-445-7795 (États-Unis/Canada) ou le 1-785-424-1699 (International) en utilisant le code d'accès SENSQ4. Un webinaire en direct sera également disponible sur le site Web de l'entreprise dans la section Relations Investisseurs et sera archivé pour référence future.
Senseonics Holdings (NYSE American: SENS), ein Medizintechnikunternehmen, das sich auf langfristige, implantierbare kontinuierliche Glukoseüberwachungssysteme für Diabetespatienten spezialisiert hat, hat die Veröffentlichung der Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 für den 3. März 2025 nach Marktschluss angesetzt.
Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um die finanziellen Ergebnisse zu besprechen. Investoren können an dem Anruf teilnehmen, indem sie 1-800-445-7795 (USA/Kanada) oder 1-785-424-1699 (International) wählen und den Zugangscode SENSQ4 verwenden. Eine gleichzeitige Webübertragung wird auf der Website des Unternehmens im Bereich Investor Relations verfügbar sein und für zukünftige Referenzen archiviert werden.
- None.
- None.
GERMANTOWN, Md., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its fourth quarter and full year 2024 financial results after market close on Monday, March 3, 2025.
Management will hold a conference call to review the Company’s fourth quarter and full year 2024 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by navigating to “Investor Relations,” and then “Events & Publications,” and will be archived there for future reference. To listen to the conference call, please dial 1-800-445-7795 (US/Canada) or 1-785-424-1699 (International), passcode SENSQ4, approximately ten to five minutes prior to start time.
About Senseonics
Senseonics Holdings, Inc. ("Senseonics") is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems Eversense® 365 and Eversense® E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.
Senseonics Investor Contact
Jeremy Feffer
LifeSci Advisors
investors@senseonics.com
FAQ
When will Senseonics (SENS) release Q4 and full year 2024 earnings?
What time is the Senseonics (SENS) Q4 2024 earnings conference call?
How can investors access the Senseonics (SENS) Q4 2024 earnings call?
Where can I find the webcast of Senseonics (SENS) Q4 2024 earnings call?
